20061 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions Aerosols; Foams
Nasal composition
#302DERMAL REJUVENATION COMPOSITIONS AND METHODS
#303Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
#304Transdermal administration of antioxidant for treatment of pain and inflammation
#305COSMETIC AND PHARMACEUTICAL FOAM
#306Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#307Topical tetracycline compositions
#308Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
#309Synthesis and application of microbubble-forming compounds
#310Topical compositions and methods for treating psoriasis
#311COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH
#312NANOBIOCOMPOSITE COMPOSITIONS AND METHODS
#313CO-PACKAGED DRUG PRODUCTS
#314PAC-1 combination therapy
#315Methods of treatment using topical copper ion formulations
#316Treatment for Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease
#317Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
#318Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use
#319Amine-functionalized polymeric compositions for medical devices
#320Therapeutic compounds and formulations for intranasal delivery
#321GNRH ANALOGUE FORMULATIONS
#322METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILM ON ANIMAL TISSUES, INCLUDING TREATMENT OF INFECTION
#323Ophthalmic lubricating spray
#324HOMEOPATHIC COMPOSITION COMPRISING HYPERICUM PERFORATUM EXTRACT AND ESSENTIAL OILS FOR THE TREATMENT OF NEUROPATHIC PAIN
#325CORTEXOLONE 17alpha-PROPIONATE FOR USE IN THE TREATMENT OF SKIN WOUNDS AND/OR ATROPHIC SKIN DISORDERS
#326Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#327Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
#328TOPICAL SPRAY SYSTEM OF HALOBETASOL
#329TOUCH-FREE TOPICAL SPRAY OF HALOBETASOL
#330Synergistic composition comprising propolis and carnosic acid for use in the prevention and treatment of candidiasis
#331Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection and granulomatous disease
#332Methods and systems for the delivery of a therapeutic agent
#333SUBLINGUAL SPRAY FORMULATION COMPRISING DIHYDROARTEMESININ
#334DERMAL REJUVENATION COMPOSITIONS AND METHODS
#335Sprayable Topical Carrier and Composition Comprising Phosphatidylcholine
#336Foamable Vehicle and Pharmaceutical Compositions Thereof
#337Topical tetracycline compositions
#338Emulsions for intrapulmonary delivery
#339TOPICAL AQUEOUS SPRAY COMPOSITIONS OF HALOBETASOL
#340Attenuated strain which protects against pathogenic infections, vaccine containing and use thereof
#341Nicotine-containing pharmaceutical compositions
#342AN INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION
#343Aerosol liposome of marine extract and method of producing the same
#344Sprayable polymers as adhesion barriers
#345Fluid delivery devices and methods
#346Body Cavity Foams
#347Acceleration of diabetic wound healing
#348Mast cell stabilizers treatment for systemic disorders
#349Lipid membrane structure for intracellular delivery of siRNA
#350Nebulisation-based method for mixing substances
#351Iron Chelators and Use Thereof for Reducing Transplant Failure During Rejection Episodes
#352VOLATILE ORGANIC COMPOUNDS FOR INHIBITING FUNGAL GROWTH
#353Positively charged co-polymers for use as antimicrobial agents
#354Use of TGF-Beta Antagonists to Treat Infants at Risk of Developing Bronchopulmonary Dysplasia
#355Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
#356Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerve
#357COMPOSITION HAVING IMPROVED SPRAYING CHARACTERISTICS COMPRISING VEGETABLE OILS AND TRIGLYCERIDES AND/OR MINERAL OILS
#358Use of miR-199a-5p, targets and/or inhibitors thereof for the diagnosis, prognosis and treatment of fibroproliferative disorders
#359Device, system and method for mixing
#360SYSTEM AND METHOD FOR DELIVERING AN ANTI-ADHESIVE SUBSTANCE TO A BODY CAVITY
#361Particulate materials
#362Rinse-off chemical mousse containing benzoyl peroxide
#363Leave-in chemical foam comprising benzoyl peroxide
#364DISPOSABLE CARTRIDGE FOR HOLDING COMPRESSED MEDICAL GAS
#365INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION
#366Tannin-chitosan composites
#367Methods for preventing and/or treating nasal polyps and rhinosinusitis
#368COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE
#369Rhinal spray nozzle used for medical syringe
#370Rhinovaccination system of influenza vaccine
#371WEARABLE PERSONAL PROTECTION SPRAY DEVICE WITH TRIGGER AND SAFETY MECHANISM
#372Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome
#373Powder for delivery to the oral cavity
#374Compounds for treatment of fluoroquinolone-resistant bacteria
#375Therapeutic compounds
#376FOAM PRODUCTION EQUIPMENT AND FOAM
#377COMPOSITION, SYSTEM AND METHOD FOR TREATING SKIN
#378Sublingual delivery of glatiramer acetate
#379Lipid compositions with high DHA content
#380Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
#381Cannabinoid compositions and uses
#382Heating unit for use in a drug delivery device
#383SALICYLIC ACID COMPOSITION
#384Degradation of Beta-Amyloid Proteins With Keratinase
#385Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD)
#386Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith
#387Concentrated, inhalable ciprofloxacin formulation
#388Aqueous composition for ophthalmological use or otolaryngological use
#389Ceramide levels in the treatment and prevention of infections
#390Compositions and methods to promote wound healing
#391Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
#392Methods of treatment using topical copper ion formulations
#393PROTECTING TISSUE AND MITIGATING INJURY FROM CHEMICAL EXPOSURE
#394Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
#395Composition comprising a polymer and a bioactive agent and method of preparing thereof
#396Drug condensation aerosols and kits
#397Topical compositions and methods for treating psoriasis
#398Mast cell stabilizers treatment for systemic disorders
#399Fluid delivery devices and methods
#400METHODS FOR THE TREATMENT OF LUNG DISEASES WITH MAST CELL STABILIZERS
#401Mast cell stabilizers treatment for systemic disorders
#402pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
#403Parenteral formulations of dopamine agonists
#404Anti-fibroblastic fluorochemical emulsion therapies
#405Aerosol formulations comprising formoterol fumarate dihydrate
#406Sprayable topical carrier and composition comprising phosphatidylcholine
#407Multidrug-Resistant Gram-Positive Bacteria Antibacterial Agent and Topical Agent
#408Pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use
#409Use of novel anti-HPV pharmaceutical preparation
#410Composition and method for treating wounds and inflammatory conditions
#411PRODUCT AND PROCESS FOR MUCUS VISCOSITY NORMALIZATION
#412Use of glyceryl trinitrate for treating traumatic edema
#413Compositions and methods for stimulating hair growth
#414Medical delivery devices and methods for applying a barrier composition to a targeted skin surface
#415Iron chelators and use thereof for reducing transplant failure during rejection episodes
#416Scarring reducing wound treatment
#417Methods and systems for the delivery of a therapeutic agent
#418METHODS AND COMPOSITIONS FOR THE DISRUPTION OF BIOFILMS AND TREATMENT OF DISORDERS CHARACTERIZED BY THE PRESENCE OF BIOFILMS
#419Methods and systems of treating wounds
#420Topical therapeutic formulations
#421Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#422Device, system and method for mixing
#423Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use
#424NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#425Nicotine salt formulations for aerosol devices and methods thereof
#426TOPICAL CORTICOSTEROID COMPOSITIONS
#427Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells
#428Pharmaceutical formulation comprising NSAID and cyclodextrin
#429Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
#430Aerosol sodium chloride mixture agent with trigger sprayer
#431Aerosol isopropyl alcohol mixture agent with trigger sprayer
#432Composition for increasing of the effectiveness of UV-B therapy, process for the preparation thereof, and its use
#433Foamable otic pharmaceutical compositions
#434Compositions and methods for stimulating hair growth
#435LIQUID AEROSOL FORMULATION OF AN ELECTRONIC SMOKING ARTICLE
#436Administration of aerosolised iloprost
#437Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
#438Antimicrobial compositions and related methods
#439Methods and compositions for transdermal delivery
#440Methods and compositions for transdermal delivery
#441Amine-functionalized polymeric compositions for medical devices
#442Methods and use of inducing apoptosis in cancer cells
#443Medical delivery devices and methods for applying a barrier composition to a targeted skin surface
#444METHOD FOR SATIATION ENHANCEMENT OF FOOD EMULSIONS USING AN AEROSOL DELIVERY SYSTEM
#445Therapeutic compounds
#446Fatty acid pharmaceutical foam
#447Topical tetracycline compositions
#448Surfactant protein D for the treatment of disorders associated with lung injury
#449Topical therapeutic formulations
#450AEROSOL DELIVERY SYSTEMS, COMPOSITIONS AND METHODS
#451Topical bioadhesive formulations
#452Kit for producing foams containing bispyridinium alkane
#453Ceramide levels in the treatment and prevention of infections
#454Oil and liquid silicone foamable carriers and formulations
#455FOAMABLE COMPOSITION AND USES THEREOF
#456Concentrated, inhalable antibiotic formulation
#457Aerosolized Dapsone as a Therapy for Inflammation of the Airway and Abnormal Mucociliary Transport
#458COMPOSITIONS FOR AEROSOLIZATION OF HIGHLY CONDUCTIVE SOLUTIONS
#459Nicotine salt formulations for aerosol devices and methods thereof
#460Lipid compositions with high DHA content
#461Foamed biocompatible materials for tissue repair
#462Gelling formulation based on calcium gluconate
#463Polymer conjugated protein micelles
#464NICOTINE SALT FORMULATIONS FOR AEROSOL DEVICES AND METHODS THEREOF
#465Container for the generation of therapeutic microfoam
#466Topical tetracycline compositions
#467High oil-content emollient aerosol foam compositions
#468Methods and compositions for the delivery of a therapeutic agent
#469Antimicrobial compositions of aminoglycosidic antibiotics and zinc ion chelators specifically formulated for enhanced inhibition of bacterial colonization and antibacterial efficacy
#470Pharmaceutical formulation comprising NSAID and cyclodextrin
#471Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
#472Composition
#473Compositions comprising salbutamol sulphate
#474Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
#475Methods and compositions for transdermal delivery of caffeine in the form of solutions or suspensions
#476Bioresorable polymer matrices and methods of making and using the same
#477Foamable carriers
#478INHALABLE PHARMACEUTICAL COMPOSITIONS
#479Penetrating pharmaceutical foam
#480Oleaginous pharmaceutical and cosmetic foam
#481Bioresorbable microparticles
#482Methods of promoting fat loss comprising administering an ALK7 inhibitor
#483Topical pharmaceutical foam composition
#484Method for treating atrophic skin scars using a mixture of botulinum toxin and air
#485Method and compositions for treating psoriasis
#486FOAMABLE COMPOSITIONS AND METHODS FOR DISORDERS OF THE SKIN OR MUCOSAL SURFACES
#487Compositions, gels and foams with rheology modulators and uses thereof
#488Oil-based foamable carriers and formulations
#489Pharmaceutical foam
#490Aerosol Formulations Comprising Formoterol Fumarate Dihydrate
#491Transdermal delivery system
#492Transdermal delivery rate control using amorphous pharmaceutical compositions
#493COMPOSITIONS FOR AEROSOLIZATIONS OF HIGHLY CONDUCTIVE SOLUTIONS
#494Inhalation Solutions
#495Silica nanoparticle agent conjugates
#496Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#497Method for preventing or treating skin tumor
#498Topical therapeutic formulations
#499Parenteral formulations of dopamine agonists
#500Foamable vehicle and pharmaceutical compositions thereof
#501Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
#502Penetrating pharmaceutical foam
#503Dermal rejuvenation compositions and methods
#504Reducing post-operative adhesion formation with intraperitoneal glutamine
#505Excipient-free Aerosol Formulation
#506Method of neutralizing an aerosol containing a compound of interest dissolved in a low pH solution
#507Antimicrobial agents
#508Cosmetic, external skin preparation, and medical instrument
#509Treatment of active infections and related compositions
#510Pheromone compositions and their use to modify behavior in different vertebrate species
#511Pheromone compositions and their use to modify behavior in different vertebrate species
#512WOUND HEALING COMPOSITIONS AND METHODS
#513Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#514Lipid compositions with high DHA content
#515Spray-Pumpable Composition Suitable for Topical Skin Application
#516Desensitizing drug product
#517Dermal rejuvenation compositions and methods
#518METHOD FOR TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS
#519Drug condensation aerosols and kits
#520Topical tetracycline compositions
#521Disposable cartridge for holding compressed medical gas
#522Toroidal pharmaceutical formulations
#523Surfactant-free, water-free formable composition and breakable foams and their uses
#524COMPRESSED GAS AEROSOLS WITH ENHANCED INTENSITY AND LONGEVITY OF ACTIVES
#525AEROSOLIZED DAPSONE AS A THERAPY FOR INFLAMMATION OF THE AIRWAY AND ABNORMAL MUCOCILIARY TRANSPORT
#526Stable liquid desoximethasone compositions with reduced oxidized impurity
#527BEPOTASTINE COMPOSITIONS
#528Compositions And Methods For Stimulating Hair Growth
#529Micelles for the solubilization of gossypol
#530Inhalable pharmaceutical compositions
#531Foam Formulations Containing at Least One Triterpenoid
#532Dry powder fibrin sealant
#533METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
#534Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion
#535Topical formulation comprising a corticosteroid as active ingredient
#536Transmucosal administration of drug compositions for treating and preventing disorders in animals
#5371,2,4-oxadiazole benzoic acids
#538Solution containing hypochlorous acid and methods of using same
#539Lipid depot formulations
#540Methods and compositions for the delivery of a therapeutic agent
#541Cosmetic, external skin preparation, and medical instrument
#542Device and method for delivery of a medicament
#543Bepotastine compositions
#544Delivery of submicrometer and nanometer aerosols to the lungs using hygroscopic excipients or dual stream nasal delivery
#545ENHANCED METHOD AND COMPOSITION FOR THE TREATMENT OF HIV+ TUBERCULOSIS PATIENTS WITH ANTI-RETROVIRAL DRUGS AND LIPOSOMAL ENCAPSULATION FOR DELIVERY OF REDUCED GLUTATHIONE
#546COMPOSITIONS COMPRISING NONSTEROIDAL ANTI - INFLAMMATORY DRUGS
#547Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
#548FORMULATIONS FOR THE TREATMENT OF DEEP TISSUE PAIN
#549LIPOSOMAL REDUCED GLUTATHIONE AND l-ARGININE, INCLUDING WITH OTHER INGREDIENT(S), CAPABLE OF MULTIPATH ADMINISTRATION FOR REVERSAL AND PREVENTION OF OBESITY AND FOR MITOCHONDRIAL BIOGENESIS
#550Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
#551Topical Delivery with a Carrier Fluid
#552Methods and formulations for treating ineffective or decreased esophagal motility
#553Methods of promoting fat loss comprising administering an ALK7 inhibitor
#5541,2,4-oxadiazole benzoic acid compositions and their use in bioassays
#555Sublingual Spray Formulation Comprising Dihydroartemesinin
#556Foamable Compositions, Kits and Methods for Hyperhidrosis
#557COMPOSITION FOR ALLEVIATING ULTRAVIOLET IRRADIATION-INDUCED DAMAGE
#558Foamable composition and uses thereof
#559PHARMACEUTICAL SOLUTION OF CETIRIZINE HYDROCHLORIDE
#560Method and Kit for Moisturizing the Surface of the Eye
#561Homeopathic Composition Comprising Hypericum Perforatum Extract And Essential Oils For The Treatment Of Neuropathic Pain
#562Topical Pharmaceutical Foam Composition
#563Composition and method for treating wounds
#564Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
#565MUCOADHESIVE XYLOGLUCAN-CONTAINING FORMULATIONS USEFUL IN MEDICAL DEVICES AND IN PHARMACEUTICAL FROMULATIONS
#566Anti-fibroblastic fluorochemical emulsion therapies
#567Pharmaceutical foam
#568Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
#569Particulate materials
#570Sublingual Pharmaceutical Composition Comprising a Neutral Oil
#571Anti-chafing aerosol powder
#572Pharmaceutical compositions for dehydrating, atrophying and eliminating pathological tissues
#573Bear bile macromolecular extract and preparation method and use thereof
#574Bioresorbable polymer matrices and methods of making and using the same
#5751,2,4-oxadiazole benzoic acid compositions
#576FATTY ACID MONOGLYCERIDE COMPOSITIONS
#577High oil-content emollient aerosol foam compositions
#578BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLIPIDEM
#579Compositions, gels and foams with rheology modulators and uses thereof
#580NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITIONS
#581PHARMACEUTICAL COMPOSITION CONTAINING MALATHION AND VOLATILE CYCLIC SILICONE
#582Compositions and methods for including melanogenesis in a subject
#583PULMONARY DELIVERY OF 17-HYDROXYPROGESTERONE CAPROATE (17-HPC)
#584TOPICAL FOAMING COMPOSITON AND METHOD OF APPLICATION
#585DRUG CONDENSATION AEROSOLS AND KITS
#586Therapeutic calcium phosphate particles and methods of manufacture and use
#587Aerosol foams comprising clindamycin phosphate
#588Method for solubilizing metronidazole
#589Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus
#590Oil and liquid silicone foamable carriers and formulations
#591Encapsulated functional fine particle composition capable of spraying and preparation method thereof
#592Surfactant protein D for the treatment of disorders associated with lung injury
#593Delivery of Drugs to Mucosal Surfaces
#594Absorption of therapeutic agents across mucosal membranes or the skin
#595SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE
#596Concentrated, inhalable ciprofloxacin formulation
#597Agent For Oral Mucosal Administration
#598Frozen compositions and methods for piercing a substrate
#599METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
#600COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH